Minodora Andor, Liana Dehelean, Ana-Maria Romosan, Valentina Buda, Gabriela Radu, Florina Caruntu, Aurora Bordejevic, Minodora Marinela Manea, Ion Papava, Cristina Ana Bredicean, Radu Stefan Romosan, Mirela Tomescu
Purpose: This research article assesses the cardiovascular impact of long-term injectable antipsychotic therapy on patients diagnosed with schizophrenia spectrum disorders. In our study, we attempted to quantify the potential causes of cardiovascular damage, assess cardiovascular parameters, and correlate them with the time elapsed from the onset of the psychosis until the initiation of injectable antipsychotic therapy, as well as the duration of long-acting therapy, and finally, to compare two of the most utilized long-acting injectable (LAI) medications (olanzapine vs risperidone)...
2019: Neuropsychiatric Disease and Treatment